Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.
about
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CarePulmonary fibrosis: pathogenesis, etiology and regulationLocalization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivoInterferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysisActivation of the AT1R/HIF-1 α /ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells.Atherogenic Cytokines Regulate VEGF-A-Induced Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells into Endothelial Cells.The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients.Manipulating the angiotensin system--new approaches to the treatment of solid tumours.Therapeutic potential of targeting the renin angiotensin system in portal hypertension.Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China.Blockade of renin-angiotensin system in antifibrotic therapy.The Effects of Taoren-Honghua Herb Pair on Pathological Microvessel and Angiogenesis-Associated Signaling Pathway in Mice Model of CCl4-Induced Chronic Liver DiseaseThe prince and the pauper. A tale of anticancer targeted agents.Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.Angiotensin inhibition and malignancies: a review.The role of the renin-angiotensin system in liver fibrosis.Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.Pharmacotherapeutic Management of Gastrointestinal Bleeding in Patients with Continuous-Flow Left-Ventricular Assist Devices.Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.Effect of AT1R knockdown on ishikawa cell proliferation induced by estrogen.Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model.Dual blockade of angiotensin-II and aldosterone suppresses the progression of a non-diabetic rat model of steatohepatitis.PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis.Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China.Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
P2860
Q26851160-036DB839-8C08-4B22-AEBA-21C8799481EFQ28388425-6B4B274A-7457-4211-A9B3-377B404FD195Q33816513-B8A0F088-84AC-476A-A29C-B349F25046BDQ33866293-522132C6-7FE3-46DF-B1F7-C2DDB435A3A5Q34371778-BC73C9B7-5E54-4B81-B276-E37C293A4D4DQ34461098-A896671C-EF01-4425-AA1E-CC63AEB412D7Q35729854-F5D1B14E-FBCF-4599-984F-E76F23660811Q36012552-752564B0-C72F-4D48-B6B2-DAC3F03EE2F4Q36407240-E2759C19-A567-41F8-9FF1-151853340117Q36769062-538915A7-971D-494B-984E-F6D82ED87FD3Q36836530-B585471E-6DBE-44D0-B5DB-AB236EACEA7EQ36849068-28D99F5E-6EC8-4237-B97D-34AC3D03DFF9Q36933012-37F1EC9A-5CFD-42A0-B8B2-F4FD53904945Q37042365-8AD7600B-6E15-468D-93DB-E15952CDE7D1Q37426714-81EC219F-D381-477E-9C48-0F9BA84DD258Q37429773-9B00ADFE-A4FF-4541-A80A-E504C71BAAD9Q37867350-809268F7-D144-4A6C-B81E-D38FC0C0FEB0Q38406281-B1FFBA33-4767-433F-ACE8-BADD1CAF7EC4Q38612227-95672405-387A-4252-9939-91AD4E675425Q38879747-07D485AB-7355-45F6-B916-17B89CBB79BBQ39367916-DD72E94F-0A02-470F-B965-6684F1628D39Q39459741-82FC6827-0730-423D-876D-7BDCCEE4D667Q39517819-8422A7DC-ECE6-4296-8D71-DAEE0D77F62AQ41197374-1AC4B98F-D581-4DF7-847E-630F606D0FF5Q42176947-41AACAB1-7278-4C43-A72B-59012A7D6228Q43106907-8650D3FD-F92C-489F-961F-24E7D5BCFE53Q43826988-F9740E8E-5ED1-42C3-842F-5B464D7D405AQ48601476-72A88F3B-2462-4710-80AF-849B63710A38Q52661962-6375F88E-99C6-442D-BFA9-18E3297610E4Q52688162-C0F5DF25-9D1D-424E-958C-DE3556FF060AQ54351805-AAAB2F96-A563-4204-8AF9-362CF19D9561Q54590269-D5E905EF-CFE7-4568-8BE0-2F8DB1E1FA62
P2860
Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@ast
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@en
type
label
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@ast
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@en
prefLabel
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@ast
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@en
P2093
P356
P1433
P1476
Angiotensin-I-converting enzym ...... lar endothelial growth factor.
@en
P2093
Hiroshi Fukui
Hitoshi Yoshiji
Shigeki Kuriyama
P2888
P304
P356
10.1159/000069792
P577
2002-11-01T00:00:00Z
P6179
1034713064